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Enteric fever (EF) (typhoid fever) is an acute infectious disease due to infection with Salmonella typhi and Salmonella paratyphi bacteria. It has become rare 
in developed nations (with the incidence of <10/100000 
population/year) due to improvement in food handling and 
water/sewage treatment. However, it remains a major public 
health issue in developing world like South Central and South 
East Asia (>100/1,00,000 population/year) [1]. An estimated 
26.9 million typhoid cases occur annually, of which 1% result 
in death [2]. In addition, an estimated 5.4 million cases of 
paratyphoid occur each year [2]. S. typhi and S. paratyphi A 
are the predominant types responsible for infection in India, 
particularly during the summer months [3].
Although EF is effectively treated with antibiotics, drug 
resistance has been reported since the 1960s [4]. First, outbreak 
of multi-drug resistant S. typhi (MDRST), defined as resistance 
to first three commonly used antibiotics viz., chloramphenicol, 
ampicillin, and co-trimoxazole, was reported in 1989 [5]. With 
the worldwide emergence of these strains, and increasing 
morbidity and mortality due to infection with these strains, 
search for more effective antibiotic/s became a necessity. 
Fluoroquinolones such as ciprofloxacin and ofloxacin emerged 
as ideal candidates, but their efficacy was also short lived as 
their wide spread, and indiscriminate use in the 1990s led 
to emergence of resistance [1,2,6-12]. Cephalolosporins, 
especially 2nd and 3rd generation drugs, were next tried and 
today, these are used as the drugs of choice against EF world 
over. However, with the widespread use of these agents, there 
is an emerging trend of fully or partially resistant strains 
of Salmonella to these drugs too [2,13-15]. More and more 
antibiotics such as azithromycin and aztreonam are being 
suggested by various authorities to treat these truly multidrug-
resistant isolates [2,16,17]. The result of this is twofold: (1) The 
cost of therapy has steadily increased, and (2) the probability of 
domiciliary management is steadily diminishing. Hence, this 
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study was undertaken to know the current antibiogram pattern 
of S. typhi and paratyphi isolates and the clinical response of 
children with culture positive EF to the specific antibiotic used 
as suggested by the antibiogram.
MATERIALS AND METHODS
This is a retrospective study involving analysis of data of 
children admitted and treated for EF over a period of 3 years 
from January 2013 to December 2015 at ESI Medical 
College and Postgraduate Institute of Medical Sciences and 
Research, Bengaluru, Karnataka, India. A total of 197 records 
of children admitted and treated for culture positive EF 
were analysed for the antibiogram pattern and their pattern 
of response to treatment to the antibiotics used as per the 
antibiogram. Kirby-Bauer disc diffusion method was used 
for antibiotic sensitivity using closed-loop stripping analysis 
standards.
Children between 1 and 18 years of age with EF whose 
blood cultures were positive for S.typhi or paratyphi included 
in the study. Children, who received antibiotic therapy before 
admission to our hospital or where incomplete records were 
available, were excluded from the study. Temperature charts 
of the patients were analyzed to assess the response pattern 
of fever to the antibiotics used and duration to defervescence 
noted.
RESULTS
Analysis of antibiograms of 197 children treated for culture 
positive EF revealed that the isolates of S. typhi (n=190) and 
S. paratyphi (n=7) were sensitive to 9 out of 10 antibiotics 
tested. Sensitivity to ciprofloxacin was 94.4% in comparison to 
sensitivity to nalidixic acid which was only 6.3%, thus showing 
discordance in patterns of sensitivity to fluoroquinolones. 
Surprisingly, sensitivity to primary three antibiotics viz., 
ampicillin, chloramphenicol, and co-trimoxazole was high 
(Table 1).
A total of 184 children were treated with intravenous 
ceftriaxone as their antibiogram showed sensitivity to 
cephalosporins (Group 1). 172 children among this group 
had become afebrile by 7 days of treatment. The remainder, 
i.e,. 12 children were considered as either having reduced 
susceptibility or resistance to this drug and were treated with 
either azithromycin or piperacillin-tazobactam over the next 
5-7 days successfully. 13 children were treated with intravenous 
ciprofloxacin as their antibiogram showed resistance to 
cephalosporins (Group 2). 9 children from this group had 
become afebrile by 7 days of treatment. The remainder, 
i.e. 4 children were considered as either having reduced 
susceptibility or resistance to this drug and were treated with 
either azithromycin or piperacillin-tazobactam over the next 
5-7 days successfully (Table 2).
DISCUSSION
In this study, we found high levels of sensitivity of S. typhi 
and S. paratyphi to both cephalosporins and fluoroquinolones, 
whereas, in a recent study, Narain and Gupta have reported 
intermediate to low sensitivity to both these groups of 
antibiotics [18]. Our study revealed high sensitivity pattern 
to the primary three antibiotics in contrast to low sensitivity 
pattern reported in the above study (Table 3). We found low 
levels of MDRST and high levels of resistance to nalidixic acid. 
Kumar et al. [12], Madhulika et al. [19], Nagshetty et al. [20], 
Bhattacharya et al. [21], and Shetty et al. [22] have all reported 
similar results in their respective studies.
The Indian network for surveillance of antimicrobial 
resistance in its large multicenter study of 3275 isolates of 
S. typhi and S. paratyphi all over India over a period of 3 years 
have reported re-emergence of susceptibility to ampicillin, 
cotrimoxazole and chloramphenicol, a decline in MDR 
strains, and a high resistance to nalidixic acid [23]. This study 
also has reported continued high efficacy of 3rd generation 
cephalosporins against these organisms. The present study is 
largely in concurrence with these findings (Table 4).
Table 1: Antibiogram showing sensitivity
Drugs S. typhi (n=190) S. paratyphi (n=7)
Sensitivity in numbers Percentage Sensitivity in numbers Percentage
Ampicillin 170 89.5 3 42.8
Cotrimoxazole 171 90 4 57.1
Cephalosporins 178 93.5 6 85.7
Furazolidone 169 88.9 6 85.7
Nalidixic acid 12 6.3 2 28.6
Ciprofloxacin 152 80.0 5 71.4
Chloramphenicol 166 87.4 7 100
Piperacillin-Tazobactam 178 93.7 7 100
Azithromycin 190 100 7 100
Tetracycline 190 100 6 85.7
S. typhi: Salmonella typhi, S. paratyphi: Salmonella paratyphi
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Table 3: Comparison of sensitivity patterns with Narain and Gupta study
Drugs S. typhi S. paratyphi
Narain and Gupta 
study (n=220)
Present 
study (n=190)
Narain and Gupta 
study (n=5)
Present 
study (n=7)
Ampicillin 131 (59.5) 170 (89.5) 3 (60) 3 (42.8)
Cotrimoxazole 148 (67.3) 171 (90) 4 (80) 4 (57.1)
Cephalosporins
Ceftriaxone
Cefotaxime
Cefuroxime
Ceftazidime
Cefperazone/salbactam
164 (74.5)
64 (29.4)
135 (61.4)
205 (93.2)
220 (100)
178 (93.7)
165 (93)
3 (60)
0 (100)
4 (80)
4 (80)
5 (100)
6 (85.7)
6 (85.7)
Furazolidone 169 (88.9) 6 (85.7)
Nalidixic acid 12 (6.3) 2 (28.6)
Ciprofloxacin
Ofloxacin
133 (58.6)
133 (60.5)
152 (80) 4 (80)
4 (80)
5 (71.4)
5 (71.4)
Chloramphenicol 205 (93.2) 166 (87.4) 3 (60) 7 (100)
Piperacillin-Tazobactam 220 (100) 178 (93.7) 5 (100) 7 (100)
Azithromycin 120 (54.5) 190 (100) 3 (60) 7 (100)
Tetracycline 190 (100) 6 (85.7)
Gentamicin
Tobramycin
Amikacin
116 (52.5)
198 (90.0)
164 (74.5)
2 (40)
5 (100)
5 (100)
Nitrofurantoin 137 (62.3) 5 (100)
Meropenem 204 (92.7) 5 (100)
S. typhi: Salmonella typhi, S. paratyphi: Salmonella paratyphi
In this study, 93% of the children in Group 1 were afebrile 
by 7 days of treatment with ceftriaxone (Table 2). This 
demonstrates that ceftriaxone used as first line drug continues 
to be very effective in inducing defervescence quickly thereby 
reducing the duration of hospital stay. There was only one 
child coming back with relapse indicating using ceftriaxone as 
the first line of therapy has almost 0% relapse rates. Hence, 
authorities recommend 3rd generation cephalosporins as the 
drug of choice in treating EF [1,2,6,16].
Kumar et al. in their article have suggested that a significant 
decrease in the proportion of MDR strains indicates that 
the MDR typhoid epidemic in the country is waning [12]. 
This may also be due to preferential use of 3rd generation 
cephalosporins as the first line of therapy by clinicians to 
treat EF in the recent times. The present study has shown 
high sensitivity pattern to the primary three antibiotics which 
throw up the possibility of using these drugs for managing EF 
Table 2: Pattern of response to antibiotic therapy
Treatment 
Groups
Day of defervescence of 
fever [days (%)]
3-5 5-7 >7 
Group 1 (n=184) 48 (26.0) 123 (67.0) 13 (7.0)
Group 2 (n=13) - 9 (69.2) 4 (30.8)
Table 4: Comparison of INSAR study with the present study
INSAR study [23] - antibiogram of S. typhi (2511) Present study (n=197)
Year 2008 (n=430) 2009 (n=694) 2010 (n=1387) 2013 (n=56) 2014 (n=63) 2015 (n=71)
Antibiotics % Sensitive % Sensitive
Ampicillin 95 96 89 87.5 90.5 90.1
Chloramphenicol 96 97 95 87.5 85.7 88.7
Cotrimoxazole 96 95 94 86.4 92.5 90.4
Ceftriaxone 100 97 100 89.3 93.7 97.2
Ciprofloxacin 99 75 59 79.3 82 80
Nalidixic acid 23 22 8.3 3.5 9.5 5.6
S. typhi: Salmonella typhi, INSAR: Indian Network for Surveillance of Antimicrobial Resistance
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in resource-poor settings, as also suggested by Kumar et al. in 
their study [12].
Treatment with cephalosporins on empirical basis needs to 
be checked both by general practitioners and specialists caring 
for children and adults to maintain the susceptibility pattern of 
Salmonella to this drug. The cost and route of administration 
make ceftriaxone less suitable in resource-poor settings. The 
oral 3rd generation cephalosporin cefixime has been reported to 
be inferior to other oral agents in terms of fever clearance time 
and treatment failure [24].
Indian Academy of Pediatrics task force on management 
of EF recommends azithromycin for oral therapy where 
initial treatment for uncomplicated EF has failed and, 
advocates use of aztreonam or imipenem as the second line for 
treatment of complicated EF [16]. Our study has shown high 
sensitivity pattern to azithromycin which can, therefore, be 
used as an effective alternative oral agent for management of 
uncomplicated EF when the cheaper oral agent is needed as 
also suggested by Crump and Mintz in their article [1].
India being a high incidence country for EF, continued 
vigilance regarding appropriate diagnosis, rational use of 
antibiotics is needed to sustain the gains. Although with the 
improving living standards and general hygiene there is a 
declining trend in incidence and prevalence, there is probably 
still a necessity for typhoid vaccine to be made part of the 
national immunization schedule. 
Our study has certain limitations; it is a retrospective study 
done in a single centre and sample size is small. Minimum 
inhibitory concentration trends of isolates could not be 
estimated as this facility was not available in our setup; hence, 
reduced susceptibility strains could not be identified.
CONCLUSIONS
Appropriate diagnosis using blood cultures and using 3rd 
generation cephalosporins as the first line of drug in treating 
children with enteric fever can reduce the duration of treatment, 
promote better compliance, reduce relapse rates, and may 
decrease multidrug resistant S.typhi/paratyphi strains in the 
community.
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